E2 ModerateModerate confidencePEM requiredObservationalPeer-reviewedMachine draft
Gastrointestinal Barrier Disruption in Post-COVID Syndrome Fatigue Patients.
Rohrhofer, Johanna, Wolflehner, Viktoria, Schweighardt, Johannes et al. · Allergy · 2025 · DOI
Quick Summary
This study looked at whether problems with the digestive system might help explain why some people develop long-lasting fatigue and other symptoms after COVID-19 (post-COVID syndrome). The researchers found that people with post-COVID fatigue had signs of gut inflammation and a leaky intestinal barrier, along with changes in immune markers in their blood. This suggests that COVID-19 may damage the gut in ways that contribute to long-term fatigue and post-exertional malaise.
Why It Matters
ME/CFS and post-COVID syndrome share overlapping symptoms including fatigue, post-exertional malaise, and autonomic dysfunction. Understanding that gut barrier integrity and immune activation may drive these symptoms opens new diagnostic and therapeutic avenues. This work may help identify which patients are at risk and suggest targets for preventing or treating post-viral fatigue syndromes.
Observed Findings
- Pre-existing gastrointestinal complaints were significantly associated with development of post-COVID fatigue.
- Post-COVID patients showed elevated LBP/sCD14 ratios compared to controls, suggesting intestinal barrier leakage.
- Post-COVID patients had lower IL-33 levels, indicating reduced regulatory immune signaling.
- Post-COVID patients had higher IL-6 levels, reflecting systemic inflammation.
- Biomarkers were detected across blood, saliva, and stool samples, indicating multi-compartment immune dysregulation.
Inferred Conclusions
- SARS-CoV-2 infection disrupts intestinal barrier function and innate immune pathways, contributing to post-viral fatigue syndrome development.
- Low-grade intestinal inflammation and barrier leakage appear to be mechanistic features distinguishing post-COVID fatigue patients from unaffected controls.
- Monitoring GI symptoms and immune markers before, during, and after viral infection may identify clinical phenotypes at risk for persistent post-viral fatigue.
- Gut-immune axis dysfunction represents a potential diagnostic and therapeutic target in post-viral fatigue syndromes.
Remaining Questions
- Does GI barrier dysfunction precede symptom onset, or does it develop during acute infection? Would interventions targeting gut integrity (probiotics, tight junction modulators, dietary measures) prevent or treat post-COVID fatigue?
What This Study Does Not Prove
This study demonstrates association between GI barrier dysfunction and post-COVID fatigue but does not prove causation—the gut disruption could be a consequence rather than a cause of fatigue. The observational design cannot establish whether specific interventions targeting gut integrity would prevent or reverse post-COVID syndrome. Results are specific to post-COVID populations and may not generalize to ME/CFS of non-viral origin.
Tags
Symptom:Post-Exertional MalaiseOrthostatic IntoleranceFatigue
Biomarker:CytokinesBlood Biomarker
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:Strong Phenotyping
Metadata
- DOI
- 10.1111/all.16593
- PMID
- 40372110
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →